3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole → HCID 24827044, Verbindung
Reaktionsgleichung
Br[C:2]1[CH:7]=[CH:6][C:5]([CH2:8][C:9]([N:11]([CH3:13])[CH3:12])=[O:10])=[CH:4][CH:3]=1.[F:14][C:15]([F:26])([F:25])[C:16]1[C:24]2[CH2:23][CH2:22][CH2:21][CH2:20][C:19]=2[NH:18][N:17]=1>>[CH3:12][N:11]([CH3:13])[C:9](=[O:10])[CH2:8][C:5]1[CH:6]=[CH:7][C:2]([N:18]2[C:19]3[CH2:20][CH2:21][CH2:22][CH2:23][C:24]=3[C:16]([C:15]([F:14])([F:26])[F:25])=[N:17]2)=[CH:3][CH:4]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared from 2-(4-bromophenyl)-N,N-dimethylacetamide and 3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole using a similar procedure to that described for Example 7.
Quellen und Nachweise
- ORD-Eintrag
- ord-6591bc3cc89e46c98992588c301e56d8
- Quelldatensatz
- uspto-grants-2010_01
- Patentnummer
- US07642256B2